Among early movers, U.S.-listed shares of Arm Holdings (NASDAQ: ARM) dropped 4% after the chip-tech provider slightly topped current-quarter expectations, but said it would no longer meet the top end ...

As the U.S. stock market approaches record highs, driven by a rally in chipmakers and positive earnings reports, investors are increasingly attentive to opportunities that may arise amidst fluctuating ...

The rest of this week brings more blue-chip earnings, plus one of the most closely watched economic data releases, the monthly jobs report. Here's a rundown: Today Earnings: Results are due premarket ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...

U.S. Treasury yields, which move inversely to prices, hovered near their lowest level in a month. More economic prints are due out this week, including the release of the all-important nonfarm ...

The TV spot marks the artificial-intelligence company's biggest foray into consumer advertising to date. Tesla sales careened lower in Germany in January, as sales of the electric vehicle company ...

The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.

Erste Group analysts upgraded Eli Lilly stock from Hold to Buy, citing a robust product demand and a promising pipeline of potential successes. The analysts highlighted the pharmaceutical company's ...

Comedians and actors Tim Robinson and Sam Richardson will star in a Super Bowl ad for Totino’s Pizza Rolls, the first Big ...

The Super Bowl is only show where viewers actually look forward to the ads. At a price tage of at least $7 million for :30.

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new product launches.